Analysts project the U.S. diabetes market will surge past $75 billion by 2031, driven by advanced cell therapies and continuous glucose monitoring systems transforming patient care [3]. Regenerative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback